Screening for liver cancer in people with cirrhosis
People with HCV cirrhosis are at risk for liver cancer, even if they have been cured by HCV treatment. Regular screening can detect early-stage liver cancer.
Usually, screening consists of a liver scan by ultrasound, computed tomography (CT) or Magnetic Resonant Imaging (MRI), and a blood test measuring alpha-fetoprotein (AFP; a protein made in foetal liver tissue).
Screening is recommended every six months.
Last updated: 17 August 2017.